Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-09-20

Clinical Trial Update: Rituximab Plus Combination Chemotherapy in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is investigating rituximab plus combination chemotherapy for patients with HIV-related non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rituximab (rituximab)

Snippet

Sponsor: Lymphoma Trials Office | Conditions: Lymphoma | Phase 1 | Status: UNKNOWN